Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Kezar Life Sciences, Inc. (KZR) had Tangible Shareholders Equity of $70.07M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-56.03M |
|
-- |
|
-- |
|
$59.11M |
|
$-59.11M |
|
$3.07M |
|
$-56.03M |
|
$-56.03M |
|
$-56.03M |
|
$-56.03M |
|
$-56.03M |
|
$-56.03M |
|
$-59.11M |
|
$-60.04M |
|
7.32M |
|
7.32M |
|
$-7.66 |
|
$-7.66 |
|
| Balance Sheet Financials | |
$75.73M |
|
$0.17M |
|
$0.92M |
|
$76.65M |
|
$6.57M |
|
-- |
|
-- |
|
$6.57M |
|
$70.07M |
|
|
Tangible Shareholders Equity |
$70.07M |
$70.07M |
|
7.33M |
|
| Cash Flow Statement Financials | |
$-51.78M |
|
$92.46M |
|
$-10.59M |
|
$41.75M |
|
$71.88M |
|
$30.13M |
|
$8.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.52 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-51.66M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-79.96% |
|
-79.96% |
|
-73.11% |
|
-79.96% |
|
$9.56 |
|
$-7.06 |
|
$-7.08 |
|